Why the study?
How should patients with ventricular arrhythmias be managed based on symptoms and the presence of underlying heart disease?
How should patients with ventricular arrhythmias be managed based on symptoms and the presence of underlying heart disease?
The management of ventricular arrhythmias is guided by the presence of symptoms and underlying structural heart disease, with therapies ranging from observation to antiarrhythmic drugs or defibrillator implantation.
Answers are grounded in this paper and cite their sources.
May inform symptom-guided ventricular arrhythmia management; leaves open prospective validation of device thresholds.
Patients with asymptomatic ventricular premature complexes who do not have evidence of heart disease should not be treated with either class I or class III (Vaughan Williams) antiarrhythmic drugs. Patients who are symptomatic may be given beta blockers. In patients who have heart disease, a number of risk factors may play a part, and the decision regarding therapy is more difficult. However, symptomatic patients with either sustained or nonsustained ventricular tachycardia must be treated with antiarrhythmic agents. In some patients, implantation of an automatic defibrillator may be necessary.
No takes yet. Share an insight, caveat, or question.
Gregory M. Marcus (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: